Cellular junctions controlling toxin entry

Cellular Lock-and-Key: How Junctions Control Toxin Entry

"Discover how a novel cellular mechanism regulates toxin entry, offering new insights into infection defense and potential therapeutic targets."


Our bodies are constantly bombarded by potential threats, from bacteria to viruses. Epithelial cells, which line our surfaces and act as the first line of defense, are particularly vulnerable. These cells are held together by specialized structures called cell-cell junctions, which maintain tissue integrity. But what if these junctions could also be manipulated by pathogens to gain entry?

Pore-forming toxins, secreted by bacteria, insert themselves into cell membranes, creating pathways for cellular damage. Staphylococcus aureus, a common bacterium, produces alpha-toxin, which targets a receptor protein called ADAM10 on our cells. This interaction leads to pore formation and, ultimately, cell death. Until recently, scientists didn't fully understand how cells regulated this process.

A recent study sheds light on the intricate dance between bacterial toxins and cell junctions. Researchers have uncovered a "dock-and-lock" mechanism that controls how ADAM10 is clustered at cell-cell junctions, influencing the cell's vulnerability to alpha-toxin. This mechanism may hold the key to developing new strategies for preventing bacterial infections.

The Dock-and-Lock: A Molecular Mechanism for Toxin Control

Cellular junctions controlling toxin entry

The research team identified key proteins involved in this process: PLEKHA7, PDZD11, Tspan33, and afadin. These proteins work together to cluster ADAM10 at cell-cell junctions, specifically adherens junctions. The process unfolds as follows:

Tspan33, a transmembrane protein, acts as the "dock" by binding to ADAM10. It then uses its cytoplasmic tail to connect with PLEKHA7.

  • PLEKHA7, along with PDZD11, creates a complex that acts as the "lock," securing Tspan33 and ADAM10 at the junction.
  • Afadin then binds directly to ADAM10, further stabilizing the cluster.
  • This clustering promotes the efficient formation of stable toxin pores, increasing the cell's susceptibility to alpha-toxin.
AI Search Multiple angles on this topic

Mapping Toxin Entry

Recent research examines bacterial toxins as substances released by bacteria to target other bacterial or host cells. Reviews distinguish toxin-delivery routes based on translocation through the endoplasmic-reticulum-associated degradation pathway from other mechanisms. Work on ABC toxins also addresses assembly, pore formation, translocation, and how these toxins recognize cellular targets. A recent study describes a “dock-and-lock” mechanism that clusters ADAM10 at cell-cell junctions and influences vulnerability to alpha-toxin.

Unresolved Junction Effects

The role of adherens junctions in toxin injury is not limited to determining whether a toxin can act. One proposed explanation is that junctions regulate cytotoxicity by controlling pore resolution and cellular membrane repair. Another possibility is that they transmit pro-death intracellular signals or localize the injury caused by pore-forming toxins. These alternatives show that the junction-toxin relationship remains mechanistically unresolved.

Conversely, when the PLEKHA7-PDZD11 complex is disrupted, ADAM10 cannot be effectively clustered at junctions. This leads to increased toxin pore removal through endocytosis, a process where the cell engulfs and internalizes the pores. As a result, cells become more resistant to the toxin and have a greater chance of survival.

Future Implications: Targeting Junctions for Infection Control

This discovery offers a new perspective on how cells regulate their interactions with pathogens. By understanding the precise mechanisms that control ADAM10 clustering at cell-cell junctions, researchers can explore novel therapeutic strategies to combat bacterial infections. These strategies might involve:

AI Search Multiple angles on this topic

Entry as a Cellular Sequence

For certain bacterial toxins, cellular entry begins with diffusion of the toxin particle and binding to a membrane receptor. Toxin-receptor complexes can then aggregate on the membrane, followed by large-scale membrane deformation and tubular invagination. This sequence places receptor organization and membrane remodeling alongside toxin binding as important parts of entry. Research on binary and pore-forming toxins extends beyond classical toxinology and microbiology into broader questions about cellular entry.

Restoring Barrier Function

Research on cholera toxin points toward barrier preservation and cellular recovery as important future directions. In intestinal epithelial cells, the enzymatic moiety CtxA increases cAMP synthesis, leading to chloride efflux through the CFTR chloride channel and the movement of sodium ions and water. A 2013 study reported that cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. A 2022 review notes that although toxin-induced chloride efflux is thought to be irreversible, altering the underlying processes could facilitate recovery from intoxication.

When Junctions Become Entry Points

A study of Staphylococcus aureus alpha-toxin identified a macromolecular complex that clusters the alpha-toxin receptor ADAM10 at cell-cell junctions. The reported dock-and-lock mechanism involves Tspan33, PLEKHA7, PDZD11, and afadin. By promoting ADAM10 clustering at junctions, this complex promotes efficient cell death caused by S. aureus alpha-toxin. The findings connect the organization of ordinary cell contacts to the severity of bacterial toxin injury.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is the role of cell-cell junctions in toxin entry?

Cell-cell junctions, specifically adherens junctions, are crucial structures that hold cells together, maintaining tissue integrity. Recent research has revealed that these junctions also play a significant role in controlling the entry of harmful toxins into cells. This is significant because it shows that pathogens can manipulate cell-cell junctions to gain entry. Understanding the function of cell junctions gives insights to create future therapies.

2

Could you explain what is meant by the "dock-and-lock" mechanism?

The "dock-and-lock" mechanism refers to the molecular process by which ADAM10 is clustered at cell-cell junctions, influencing a cell's vulnerability to alpha-toxin. Tspan33 acts as the "dock" by binding to ADAM10, then connects with PLEKHA7. The PLEKHA7-PDZD11 complex acts as the "lock," securing Tspan33 and ADAM10 at the junction, with afadin further stabilizing the cluster. This mechanism regulates toxin entry, providing new therapeutic strategies to fight bacterial infections.

3

What is the role of ADAM10 in bacterial toxin entry?

ADAM10 is a receptor protein on our cells targeted by alpha-toxin, which is produced by Staphylococcus aureus. This interaction leads to pore formation in the cell membrane and, ultimately, cell death. The clustering of ADAM10 at cell-cell junctions, facilitated by the "dock-and-lock" mechanism, promotes the formation of stable toxin pores, increasing the cell's susceptibility to alpha-toxin. Therefore, controlling ADAM10 clustering is crucial in determining a cell's resistance or vulnerability to bacterial toxins.

4

How do PLEKHA7 and PDZD11 influence toxin resistance?

PLEKHA7 and PDZD11 work together to create a complex that acts as the "lock" in the "dock-and-lock" mechanism, securing Tspan33 and ADAM10 at the adherens junction. When this complex is disrupted, ADAM10 cannot be effectively clustered at junctions, leading to increased toxin pore removal through endocytosis. This disruption makes cells more resistant to toxins and increases their chance of survival, highlighting the importance of this complex in regulating toxin entry.

5

What are the future implications of this research for infection control?

Targeting junctions for infection control involves developing therapeutic strategies that manipulate the "dock-and-lock" mechanism to prevent bacterial infections. This could involve disrupting the PLEKHA7-PDZD11 complex to inhibit ADAM10 clustering or enhancing endocytosis to remove toxin pores more efficiently. These strategies aim to increase cells' resistance to toxins and reduce the severity of bacterial infections. Further research into the precise mechanisms controlling ADAM10 clustering at cell-cell junctions is essential for developing these novel therapies.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.